Aug 5, 2004

Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia

Neuropsychobiology
Vincenzo De LucaJames L Kennedy

Abstract

Most antipsychotic drugs act on the forebrain by blocking dopamine receptors. In rodents, the M5 muscarinic receptor (CHRM5) is important for prolonged dopamine release. We typed polymorphisms in CHRM5 and alpha7-nicotinic receptor (CHRNA7) genes on 15q13 in 82 Canadian families having at least 1 schizophrenic patient. Using the Family-Based Association Test, we performed haplotype analysis of the 2 loci and found biased transmission in schizophrenia (z = -2.651, p = 0.008). In the families tested, the 2 cholinergic genes interacted to affect schizophrenia in combination, while neither was sufficiently alone to confer susceptibility. Our present study provided the first line of direct evidence suggesting that the CHRM5 gene combined with the CHRNA7 gene may be linked to schizophrenia.

  • References
  • Citations35

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

Receptor, Muscarinic M5
Schizophrenia
Chrna7 protein, human
Alpha7 Nicotinic Acetylcholine Receptor
Antipsychotic Agents
CHRM5 gene
Dopamine Measurement
Dopamine
Genetic Equilibrium
Dopamine Receptor

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here